atoms & art
Robert Dekker is a founding partner of atoms & art, a company supporting biotech, medtech and start-ups. He has >20 years of international experience in biopharmaceutical research, regulatory affairs, product development and business development. From 2007 to 2014 Robert held several functions within TiGenix NV. He was director new product commercialization leading the cross-functional team on decision-making for new indications and strategic development of the technology platform.
Within business development, he was responsible for portfolio management through licensing and distribution agreements. As a member of the R&D department, he managed new product development and contributed to the marketing authorization of the first advanced therapy medicinal product.
Between 2002 and 2007 he was Scientific Assessor at the Medicines Evaluation Board in The Netherlands and a core member in the working party on cell-based products at the European Medicines Agency.
Robert holds a MSc degree in medical biology from the University of Amsterdam and a PhD in bone tissue engineering obtained at IsoTis BV.